Penumbra (PEN) Accumulated Expenses (2014 - 2026)
Penumbra's (PEN) quarterly Accumulated Expenses came in at $151.5 million in Q1 2026, up 34.5% year-on-year from $112.7 million in Q1 2025, and up 14.66% on a QoQ basis from $132.2 million in Q4 2025.
Penumbra (PEN) Accumulated Expenses (2014 - 2026) Analysis & Trends
Penumbra (PEN) has 13 years of Accumulated Expenses data on file, last reported at $151.5 million in Q1 2026.
- On a quarterly basis, Accumulated Expenses rose 34.5% year-over-year to $151.5 million in Q1 2026; TTM through Mar 2026 was $151.5 million, a 34.5% increase from a year earlier, with the FY2025 full-year figure at $132.2 million, up 17.55% from the prior year.
- Accumulated Expenses for Q1 2026 stood at $151.5 million, up from $132.2 million in the prior quarter.
- Over the last five years, Accumulated Expenses for PEN reached as high as $151.5 million in Q1 2026 and fell as low as $101.7 million in Q3 2022.
- Historically, Accumulated Expenses has averaged $112.6 million across 5 years, with a median of $106.5 million in 2024.
- Across the five-year window, Accumulated Expenses slipped 5.21% in 2023 and jumped 34.5% in 2026, its largest moves.
- Year by year, Accumulated Expenses stood at $106.3 million in 2022, then climbed by 4.0% to $110.6 million in 2023, then gained by 1.7% to $112.4 million in 2024, then gained by 17.55% to $132.2 million in 2025, then increased by 14.66% to $151.5 million in 2026.
- Per Business Quant data, the three most recent Accumulated Expenses figures were $151.5 million in Q1 2026, $132.2 million in Q4 2025, and $124.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Penumbra | 12.48 Bn | 11.87 Bn | 253.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 151.54 Mn |
| Dec 31, 2025 | 132.16 Mn |
| Sep 30, 2025 | 124.27 Mn |
| Jun 30, 2025 | 114.39 Mn |
| Mar 31, 2025 | 112.68 Mn |
| Dec 31, 2024 | 112.43 Mn |
| Sep 30, 2024 | 105.55 Mn |
| Jun 30, 2024 | 104.07 Mn |
| Mar 31, 2024 | 106.55 Mn |
| Dec 31, 2023 | 110.56 Mn |
| Sep 30, 2023 | 104.18 Mn |
| Jun 30, 2023 | 105.61 Mn |
| Mar 31, 2023 | 105.87 Mn |
| Dec 31, 2022 | 106.30 Mn |
| Sep 30, 2022 | 101.67 Mn |
| Jun 30, 2022 | 111.41 Mn |
| Mar 31, 2022 | 105.53 Mn |
| Dec 31, 2021 | 99.80 Mn |
| Sep 30, 2021 | 93.22 Mn |
| Jun 30, 2021 | 86.50 Mn |